Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-13

FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron). The granisetron product is used to prevent chemotherapy- and surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SANCUSO (GRANISETRON)

Snippet

SUPPL AP for SANCUSO (GRANISETRON)